机译:低风险儿科结节性淋巴细胞优势Hodgkin淋巴瘤中的变体组织学,IGD和CD30表达:儿童肿瘤学群的报告
Division of Clinical PathologyState University of New York Upstate Medical UniversitySyracuse New;
Division of Clinical PathologyState University of New York Upstate Medical UniversitySyracuse New;
Hematology/Oncology Institute for Pediatric Cancer &
Blood DisordersHackensack University Medical;
Children's Oncology GroupUniversity of FloridaGainesville Florida;
Department of Information SciencesCity of HopeDuarte California;
Statistics Children's Oncology GroupMonrovia California;
Radiation OncologyPrincess Margaret Cancer CentreToronto Ontario Canada;
Department of SurgeryUniversity of MichiganAnn Arbor Michigan;
Department of Radiation OncologyUniversity of RochesterRochester New York;
Children's Hospital of WisconsinUniversity of Texas MD Anderson Cancer CenterHouston Texas;
Division of Clinical PathologyState University of New York Upstate Medical UniversitySyracuse New;
children; histology; Hodgkin; lymphoma; pathology;
机译:低风险儿科结节性淋巴细胞优势Hodgkin淋巴瘤中的变体组织学,IGD和CD30表达:儿童肿瘤学群的报告
机译:结节性淋巴细胞为主的霍奇金淋巴瘤中不同组织学对预后的影响:德国霍奇金研究小组(GHSG)的一份报告
机译:变异组织学中变异组织学中的结节性淋巴细胞 - 主要霍奇金淋巴瘤的预后影响:德国霍奇金研究组的报告(GHSG)
机译:荧光原位杂交(FISH)和非霍奇金淋巴瘤(NHL)亚型的危险因素,定义为t(14; 18)易位和bcl-2表达。
机译:低危儿科结节性淋巴细胞为主的霍奇金淋巴瘤中不同组织学IgD和CD30表达:儿童肿瘤学组的一份报告
机译:变体组织学结节淋巴细胞主要霍奇金淋巴瘤 - 转化途径?